A Harvard lab proved that aging is caused by corrupted epigenetic information — not worn-out DNA — and that it may be reversible. Here's what the research actually shows.
In January 2023, a research team led by David Sinclair at Harvard Medical School published a paper in *Cell* that many scientists called one of the most important aging papers in decades. The title — "Loss of epigenetic information as a cause of mammalian aging" — sounds technical. The implications are anything but.
The paper's central claim is simple and radical: aging is not primarily caused by your DNA breaking down. It's caused by your cells losing track of which genes to switch on and off. The genome is the hardware. The epigenome — the system of chemical marks and protein packaging that tells genes what to do — is the software. And the software is corrupting over time.
More importantly, the paper demonstrated that this corruption may be reversible.
To understand the Sinclair lab's findings, you need to understand what the epigenome actually is. Every cell in your body contains essentially the same DNA — the same sequence of 3 billion base pairs. Yet a liver cell looks nothing like a neuron, which looks nothing like a skin cell. The difference isn't in the DNA sequence; it's in which parts of that sequence are active.
The epigenome determines this. It consists of chemical tags attached to DNA and to the histone proteins that DNA wraps around. Some tags silence genes. Others activate them. The specific pattern of these marks gives each cell its identity — its "cell type" — and maintains it over years of cell division.
Young cells maintain these epigenetic marks with remarkable fidelity. Old cells do not. As we age, epigenetic marks become disorganized. Genes that should be silenced start whispering. Genes that should be active go quiet. Cells begin to lose their identity. This progressive loss of epigenetic information is what the Sinclair lab calls epigenetic noise, and their paper argues it is a root cause of mammalian aging.
This idea — called the Information Theory of Aging — was proposed by Sinclair in his 2019 book *Lifespan* and formalized through years of laboratory work. The 2023 Cell paper is the scientific proof of concept.
The core experiment in the paper involved inducing DNA breaks in mice — specifically, double-stranded DNA breaks (DSBs) of the kind caused naturally by radiation, oxidative stress, replication errors, and normal cellular metabolism. These breaks happen constantly throughout your life, and your cells are very good at repairing them. But repair has a cost.
When a DNA break occurs, the cell's repair machinery mobilizes. Chromatin remodeling factors — proteins responsible for maintaining the epigenetic landscape — temporarily abandon their normal positions on the genome to assist with repair. Think of it as the maintenance crew leaving their posts to respond to an emergency. After repair is complete, they return to their stations. But after millions of repairs over a lifetime, the crew doesn't always find exactly the right seat. Small errors accumulate. The epigenetic landscape becomes progressively more disorganized.
This is the mechanism: DNA damage response → epigenetic disruption → loss of cell identity → aging.
The Sinclair team showed that by inducing controlled, reversible DNA breaks (using a technique called the ICE system — Inducible Changes to the Epigenome), they could dramatically accelerate aging in mice. Mice that received the ICE treatment showed accelerated biological aging across multiple tissues — their DNA methylation clocks (a validated measure of epigenetic age) advanced significantly faster than controls.
This confirmed that it's the epigenetic disruption, not the DNA damage itself, that drives aging.
Here is where the paper becomes genuinely remarkable.
If aging is caused by software corruption — not hardware degradation — then in principle, the software can be re-installed. This is what the Sinclair lab tested. Using a set of transcription factors called OSK (Oct4, Sox2, and Klf4 — three of the four Yamanaka factors used in stem cell reprogramming), they partially reprogrammed aged cells.
The results were striking. In aged mice treated with OSK via gene therapy:
The key word is *partial* reprogramming. Full reprogramming would turn the cells back into stem cells, erasing their identity — potentially causing cancer. The Sinclair lab found that partial reprogramming with OSK retained cell identity while resetting the epigenetic clock. The cells kept their type but forgot their age.
The paper is in mice, and the leap from mouse to human is never guaranteed. But the mechanistic logic is compelling, and the finding that aging can be reversed — not just slowed — in a mammalian system is a significant scientific milestone.
Several things make this research relevant to humans right now:
1. Epigenetic clocks work in humans. The DNA methylation aging clocks used to measure biological age in this study were originally developed for humans. These clocks are validated predictors of mortality and disease risk. The same aging mechanism appears to operate in human cells.
2. Sirtuins are the link to existing longevity research. One of the key players in the epigenetic maintenance system is a family of proteins called sirtuins — and sirtuins require NAD+ as a cofactor. This is the connection between the epigenetic theory of aging and the NAD+ supplementation research Sinclair has championed. When NAD+ levels fall (as they do with age), sirtuin activity declines, epigenetic maintenance degrades, and the corruption accelerates.
3. The lifestyle interventions already proven to work align with this framework. Exercise, caloric restriction, and good sleep all support NAD+ levels and sirtuin activity. The information theory of aging provides a unified mechanistic explanation for why these interventions help.
While full epigenetic reprogramming remains in early research stages, several interventions target the mechanisms identified in this research:
Sirtuins — the proteins that maintain epigenetic marks during DNA repair — are NAD+-dependent enzymes. Without adequate NAD+, sirtuins cannot function properly, and epigenetic maintenance breaks down. NAD+ levels decline approximately 50% between age 20 and 60.
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are two established approaches to boosting NAD+ levels. Sinclair himself takes NMN daily and has published research showing NMN improves metabolic function in aging mice. Typical dosing: 500–1000 mg NMN or 300 mg NR daily.
Resveratrol is a natural compound that activates SIRT1, the sirtuin most directly involved in epigenetic maintenance during DNA repair. The research on resveratrol in humans is mixed, but the mechanistic connection to the epigenetic theory is clear.
Trans-resveratrol (500–1000 mg daily) is more bioavailable than standard resveratrol. Sinclair takes resveratrol dissolved in olive oil to improve absorption. Pterostilbene — a resveratrol analog found in blueberries — may have superior bioavailability and is increasingly used as an alternative.
Spermidine is a naturally occurring polyamine that promotes autophagy (cellular cleanup) and has been associated with maintenance of histones — the protein packaging that epigenetic marks are written on. Population studies link higher dietary spermidine intake to reduced all-cause mortality. Supplements derived from wheat germ (1–5 mg daily) are available, or you can increase intake through spermidine-rich foods such as aged cheese, mushrooms, and legumes.
AKG is a key intermediate in the Krebs cycle that also serves as a cofactor for histone demethylases — enzymes that help erase and reset epigenetic marks. Some researchers believe AKG supplementation supports epigenetic rejuvenation by maintaining the enzymatic machinery that writes and erases histone modifications. Calcium alpha-ketoglutarate (1000 mg daily) is the most studied form in aging research.
One insight from the paper that doesn't receive enough attention is the concept of an epigenetic reserve. Sinclair's team found evidence for a backup copy of youthful epigenetic information stored in cells — a kind of master template that can be accessed during reprogramming to restore the youthful pattern.
If this holds in human cells (evidence suggests it does), it means that the information needed to reverse biological aging is already inside you. It hasn't been destroyed by decades of living. It's been buried under layers of accumulated noise. The challenge is finding a safe way to access it.
This is the scientific basis for the emerging field of partial cellular reprogramming, which is attracting billions of dollars in investment from companies like Altos Labs, Retro Biosciences, and others.
While gene therapy-based reprogramming is years away from human application, the mechanistic framework from this paper informs practical decisions you can make today:
Protect your epigenome from accelerated degradation:
Support the cellular infrastructure that maintains epigenetic fidelity:
Track your biological age — DNA methylation clocks are becoming increasingly accessible through consumer testing services. Tracking your epigenetic age gives you a feedback mechanism to assess whether your interventions are working.
The Sinclair lab's 2023 Cell paper provides the most rigorous experimental demonstration to date that epigenetic information loss is a driver — not merely a consequence — of mammalian aging. It establishes a mechanistic chain: DNA breaks → repair response → epigenetic disruption → aging.
More importantly, it shows that aging driven by this mechanism can be reversed in mice using partial epigenetic reprogramming. The cells maintained their identity but shed their biological age.
This is a scientific milestone because it frames aging as a recoverable state rather than inevitable hardware failure. The software can be reloaded. Whether human reprogramming therapies will reach the clinic within a decade or two decades remains to be seen, but the theoretical and experimental foundation has been laid.
In the meantime, protecting your epigenome — through the lifestyle and supplement interventions that support NAD+, sirtuins, and epigenetic maintenance — is the most direct action you can take based on this science.
For more on the specific interventions that target this pathway, see our NMN/NR intervention page (Limited evidence) and explore how other longevity experts think about epigenetic aging at the David Sinclair expert profile.
*As an Amazon Associate, Stacking Years earns from qualifying purchases. Product links above are provided for convenience and do not constitute medical advice.*